Literature DB >> 22469618

Molecular imaging for personalized cancer care.

Moritz F Kircher1, Hedvig Hricak, Steven M Larson.   

Abstract

Molecular imaging is rapidly gaining recognition as a tool with the capacity to improve every facet of cancer care. Molecular imaging in oncology can be defined as in vivo characterization and measurement of the key biomolecules and molecularly based events that are fundamental to the malignant state. This article outlines the basic principles of molecular imaging as applied in oncology with both established and emerging techniques. It provides examples of the advantages that current molecular imaging techniques offer for improving clinical cancer care as well as drug development. It also discusses the importance of molecular imaging for the emerging field of theranostics and offers a vision of how molecular imaging may one day be integrated with other diagnostic techniques to dramatically increase the efficiency and effectiveness of cancer care.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22469618      PMCID： PMC5528375          DOI： 10.1016/j.molonc.2012.02.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


  122 in total

1.  Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.

Authors:  Caroline A Connell; June Corry; Alvin D Milner; Annette Hogg; Rodney J Hicks; Danny Rischin; Lester J Peters
Journal:  Head Neck       Date:  2007-11       Impact factor: 3.147

2.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

Authors:  Miriam Benezra; Oula Penate-Medina; Pat B Zanzonico; David Schaer; Hooisweng Ow; Andrew Burns; Elisa DeStanchina; Valerie Longo; Erik Herz; Srikant Iyer; Jedd Wolchok; Steven M Larson; Ulrich Wiesner; Michelle S Bradbury
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

3.  Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.

Authors:  Howard I Scher; Tomasz M Beer; Celestia S Higano; Aseem Anand; Mary-Ellen Taplin; Eleni Efstathiou; Dana Rathkopf; Julia Shelkey; Evan Y Yu; Joshi Alumkal; David Hung; Mohammad Hirmand; Lynn Seely; Michael J Morris; Daniel C Danila; John Humm; Steve Larson; Martin Fleisher; Charles L Sawyers
Journal:  Lancet       Date:  2010-04-14       Impact factor: 79.321

4.  Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma.

Authors:  D Rayson; E Bouttell; F Whiston; L Stitt
Journal:  J Surg Oncol       Date:  2000-11       Impact factor: 3.454

5.  A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.

Authors:  E E Graves; S J Nelson; D B Vigneron; C Chin; L Verhey; M McDermott; D Larson; P K Sneed; S Chang; M D Prados; K Lamborn; W P Dillon
Journal:  Neurosurgery       Date:  2000-02       Impact factor: 4.654

6.  Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.

Authors:  Ken Herrmann; Hinrich A Wieder; Andreas K Buck; Marion Schöffel; Bernd-Joachim Krause; Falko Fend; Tibor Schuster; Christian Meyer zum Büschenfelde; Hans-Jürgen Wester; Justus Duyster; Christian Peschel; Markus Schwaiger; Tobias Dechow
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

7.  Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Authors:  Sarah Everitt; Rodney J Hicks; David Ball; Tomas Kron; Michal Schneider-Kolsky; Tania Walter; David Binns; Michael Mac Manus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-20       Impact factor: 7.038

8.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

9.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

10.  A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.

Authors:  T A Smith; J Glaholm; M O Leach; L Machin; D J Collins; G S Payne; V R McCready
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640
View more
  51 in total

Review 1.  Molecular imaging for personalized cancer care.

Authors:  Moritz F Kircher; Hedvig Hricak; Steven M Larson
Journal:  Mol Oncol       Date:  2012-03-10       Impact factor: 6.603

2.  Molecular imaging of thrombus: technology in evolution.

Authors:  Jonathan R Lindner
Journal:  Circulation       Date:  2012-05-30       Impact factor: 29.690

3.  Molecular cardiovascular imaging is ready for prime time: almost there.

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

4.  Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.

Authors:  Sara Rapic; Christel Vangestel; Jeroen Verhaeghe; Tim Van den Wyngaert; Rukun Hinz; Marleen Verhoye; Patrick Pauwels; Steven Staelens; Sigrid Stroobants
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

5.  Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

Authors:  Mojtaba Ghasemi; Iraj Nabipour; Abdolmajid Omrani; Zeinab Alipour; Majid Assadi
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-11-30

6.  Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium.

Authors:  Orazio Schillaci; Nicoletta Urbano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04       Impact factor: 9.236

7.  64Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor.

Authors:  Max A Kruziki; Brett A Case; Jie Y Chan; Elizabeth J Zudock; Daniel R Woldring; Douglas Yee; Benjamin J Hackel
Journal:  Mol Pharm       Date:  2016-10-10       Impact factor: 4.939

8.  [Imaging in oncology: terms and definitions].

Authors:  P Brader; Y Menu; S Kreuzer; S Polanec; M Mayerhoefer; C J Herold
Journal:  Radiologe       Date:  2013-04       Impact factor: 0.635

9.  Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle.

Authors:  Shaunagh McDermott; Sarah P Thayer; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; Ralph Weissleder; Mukesh G Harisinghani
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 10.  Current Status of Hybrid PET/MRI in Oncologic Imaging.

Authors:  Andrew B Rosenkrantz; Kent Friedman; Hersh Chandarana; Amy Melsaether; Linda Moy; Yu-Shin Ding; Komal Jhaveri; Luis Beltran; Rajan Jain
Journal:  AJR Am J Roentgenol       Date:  2015-10-22       Impact factor: 3.959
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.